Читать книгу Handbook of Diabetes - Rudy Bilous - Страница 60

Comparative prevalence for IGT vary by region with rates almost double those for type 2 diabetes in Africa, but slightly lower elsewhere (Figure 7.5). These differences are almost certainly a reflection of socio‐economic factors as well as a paucity of studies in many African countries where extrapolation is necessary between very different populations. In Europe, the comparative prevalence will increase slightly from 9.1% in 2007 to 9.6% in 2025, representing an absolute change from 65.3 to 71.2 million (UK figures 4.7% to 4.9%, 2.17 to 2.4 million respectively).